[The analysis of different treatment methods for 184 cases of soft tissue sarcoma].
OBJECTIVE
To study the proper way of using combined postoperative chemo-radiotherapy and prognostic factors of soft tissue sarcoma.


METHODS
The clinical data of 184 patients were retrospectively reviewed. These patients were devided into surgery group (S, 94 patients), surgery plus postoperative radiotherapy group (S + R, 62 patients) and surgery plus chemotherapy group (S + C, 28 patients).


RESULTS
The 5-year survival rates of S, S + R and S + C groups were 39.4%, 48.4% and 28.6%, respectively. Combined multitherapy was the key to improve survival rate and life quality. Clinical stage, pathological type and therapeutic method were also important prognostic factors for the long term survival.


CONCLUSIONS
Surgery plus postoperative radiotherapy can improve the 5-year survival rate of soft tissue sarcoma.
Luo
Ying
Y
Department of Radiation Oncology, Hunan Cancer Hospital, Changsha 410006, China. chqing@tom.com
Chen
Zhang-Ding
ZD
Hu
Bing-Qiang
BQ
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D017024:Chemotherapy, Adjuvant; D002648:Child; D002675:Child, Preschool; D018223:Dermatofibrosarcoma / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008080:Liposarcoma / Q000401:mortality / Q000556:secondary / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D012186:Retroperitoneal Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D015996:Survival Rate